1. Home
  2. AVPT vs AMPH Comparison

AVPT vs AMPH Comparison

Compare AVPT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AvePoint Inc.

AVPT

AvePoint Inc.

HOLD

Current Price

$10.27

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$17.83

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVPT
AMPH
Founded
2001
1996
Country
United States
United States
Employees
3443
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
971.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
AVPT
AMPH
Price
$10.27
$17.83
Analyst Decision
Buy
Buy
Analyst Count
12
8
Target Price
$16.64
$28.38
AVG Volume (30 Days)
1.8M
586.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
$25.00
$6.90
Revenue Next Year
$19.63
$4.64
P/E Ratio
$1,348.94
$129.43
Revenue Growth
N/A
N/A
52 Week Low
$8.84
$16.65
52 Week High
$19.95
$31.26

Technical Indicators

Market Signals
Indicator
AVPT
AMPH
Relative Strength Index (RSI) 51.63 38.40
Support Level $9.24 $17.03
Resistance Level $10.40 $24.16
Average True Range (ATR) 0.55 0.88
MACD -0.00 -0.32
Stochastic Oscillator 38.36 14.87

Price Performance

Historical Comparison
AVPT
AMPH

About AVPT AvePoint Inc.

AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: